Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
RMD Resmed Inc
- Stocks
- Healthcare
- NYSE: RMD
Price (delayed)
$258.07
Market cap
$37.84B
P/E Ratio
28.87
Dividend/share
$2.12
EPS
$8.94
Enterprise value
$37.75B
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory
Highlights
Resmed's quick ratio has increased by 48% YoY and by 21% from the previous quarter
RMD's net income is up by 37% YoY and by 5% QoQ
The price to earnings (P/E) is 31% lower than the 5-year quarterly average of 41.9 but 3.1% higher than the last 4 quarters average of 28.0
Key stats
What are the main financial stats of RMD
Market
Valuations
Earnings
Shares outstanding
146.63M
Market cap
$37.84B
Enterprise value
$37.75B
Price to earnings (P/E)
28.87
Price to book (P/B)
6.83
Price to sales (P/S)
7.54
EV/EBIT
23.82
EV/EBITDA
20.96
EV/Sales
7.52
Revenue
$5.02B
Gross profit
$2.95B
Operating income
$1.61B
Net income
$1.31B
EBIT
$1.58B
EBITDA
$1.8B
Free cash flow
$1.57B
Per share
Balance sheet
Liquidity
EPS
$8.94
EPS diluted
$8.91
Free cash flow per share
$10.69
Book value per share
$37.76
Revenue per share
$34.23
TBVPS
$29.22
Total assets
$7.57B
Total liabilities
$2.02B
Debt
$839.77M
Equity
$5.55B
Working capital
$2.27B
Debt to equity
0.15
Current ratio
3.41
Quick ratio
1.96
Net debt/EBITDA
-0.05
Margins
Efficiency
Dividend
EBITDA margin
35.9%
Gross margin
58.8%
Net margin
26.2%
Operating margin
32.1%
Return on assets
18.2%
Return on equity
25.2%
Return on invested capital
47.8%
Return on capital employed
23.9%
Return on sales
31.6%
Dividend yield
0.82%
DPS
$2.12
Payout ratio
23.7%
RMD stock price
How has the Resmed stock price performed over time
Intraday
0.82%
1 week
0.43%
1 month
2.14%
1 year
34.18%
YTD
12.85%
QTD
0.03%
Financial performance
How have Resmed's revenue and profit performed over time
Revenue
$5.02B
Gross profit
$2.95B
Operating income
$1.61B
Net income
$1.31B
Gross margin
58.8%
Net margin
26.2%
RMD's net income is up by 37% YoY and by 5% QoQ
RMD's operating income is up by 33% YoY and by 3.3% QoQ
Resmed's net margin has increased by 25% YoY and by 3.6% QoQ
RMD's operating margin is up by 21% year-on-year
Price vs fundamentals
How does RMD's price correlate with its fundamentals
Growth
What is Resmed's growth rate over time
Valuation
What is Resmed stock price valuation
P/E
28.87
P/B
6.83
P/S
7.54
EV/EBIT
23.82
EV/EBITDA
20.96
EV/Sales
7.52
The EPS has increased by 37% YoY and by 5% from the previous quarter
The price to earnings (P/E) is 31% lower than the 5-year quarterly average of 41.9 but 3.1% higher than the last 4 quarters average of 28.0
RMD's P/B is 21% below its 5-year quarterly average of 8.6 but 8% above its last 4 quarters average of 6.3
RMD's equity is up by 20% year-on-year and by 6% since the previous quarter
The P/S is 13% higher than the last 4 quarters average of 6.7 but 8% lower than the 5-year quarterly average of 8.2
The company's revenue rose by 10% YoY
Efficiency
How efficient is Resmed business performance
The company's return on invested capital rose by 49% YoY and by 4.8% QoQ
The ROA has increased by 29% YoY and by 2.2% from the previous quarter
The ROS has increased by 17% YoY
Resmed's ROE has increased by 15% YoY
Dividends
What is RMD's dividend history
DPS
$2.12
Dividend yield
0.82%
Payout ratio
23.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Resmed financials performed over time
Resmed's quick ratio has increased by 48% YoY and by 21% from the previous quarter
The current ratio has grown by 12% YoY and by 2.4% from the previous quarter
Resmed's debt is 85% lower than its equity
Resmed's debt to equity has decreased by 40% YoY and by 6% QoQ
Resmed's debt has decreased by 28% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.